baber/WOPTO huggingface dataset:
Patent NZ-507965-A (NZ)
Title: Water soluble azoles as broad-spectrum antifungals
Inventor: MEERPOEL LIEVEN
IPC: C07D319/00
Filed: 1999-05-06
Abstract: In formula (I): L represents a radical of formula a), b), c), d), e) or f); wherein each Alk independently represents an optionally substituted C1-6alkanediyl; n is 1, 2 or 3; Y is O, S or NR2; R1 represents hydrogen, aryl, Het1, or an optionally substituted C1-6alkyl; each R2 independently represents hydrogen or C1-6alkyl; or in case R1 and R2 are attached to the same nitrogen atom, they may be taken together to form a heterocyclic radical which may be substituted; or they may be taken together to form an azido radical; each R3 independently represents hydrogen, hydroxy or C1-4alkyloxy; aryl represents phenyl, naphthalenyl, 1,2,3,4-tetrahydro-naphthalenyl, indenyl or indanyl; each of said aryl groups may optionally be substituted; Het1 represents an optionally substituted monocyclic or bicyclic heterocyclic radical; Het2 is the same as Het1 and may also be optionally substituted piperazinyl, homopiperazinyl, 1,4-dioxanyl, morpholinyl, thiomorpholinyl; R6 represents hydrogen or C1-4alkyl; R7 represents hydrogen or C1-4alkyl; or R6 and R7 taken together form a bivalent radical of formula -N=CH-(i), -CH=N-(ii), -CH=CH- (iii) or CH2-CH2-(iv), wherein one hydrogen atom in the radicals (i) and (ii) and one or more hydrogen atoms in radicals (iii) and (iv) may be optionally replaced with a C1-4alkyl radical; and D represents formula D1 or D2, wherein X is N or CH; R4 is hydrogen or halo and R5 is halo. The compounds may be used in medicaments, and particularly as antifungals.
Patent NZ-508711-A (NZ)
Title: Method for steam pressing composite board having at least one finished surface
Inventor: VERGARA ALEX
IPC: B27N3/08
Filed: 1999-07-08
Abstract: In a method for making composite wood products having a market ready finished surface, a mat is formed of wood fibres treated with a binder.  The mat is loaded into a press cavity formed between two press platens.  The first press platen is a conventional hot press platen free of ports.  The conventional platen can be smooth or patterned to emboss the finished surface on the product.  The other press platen has steam injection ports.  The press cavity is capable of being sealed.  The mat is fully consolidated.  Heat conducted from the first press platen to a first side of the mat vaporizes moisture in a portion of the thickness of the mat closest to the first side causing the moisture to greatly expand in volume.  The expanded volume is vented through an opposite side of the mat to purge trapped air from the mat.  The vapour expansion is vented from the mat through the steam injection ports, carrying with it trapped air and moisture.  Subsequent to purging of the trapped air, the press cavity is sealed and a quantity of steam from an external source is injected by way of the steam injection ports into the mat at a sufficient pressure and for a sufficient time to cure the binder.  The quantity of steam from the external source is vented from mat through the steam injection ports before the press cavity is unsealed.
Patent NZ-510720-A (NZ)
Title: Cytokine/multimer complexes as cytokine antagonists
Inventor: STAHL NEIL
IPC: C12N15/12
Filed: 1999-09-22
Abstract: Ligand trap antagonist molecules composed of two or more fusion protein units that comprise of cytokine-binding portions and a multimerising component, which multimerises with a similar such component of another such fusion polypeptide. So that when the cytokine-binding portions bind to a cytokine, cytokine/multimer complex is formed that is non-functional in the sense that it does not initiate, that is, it antagonizes signal transduction by the cytokine.
Patent NZ-514575-A (NZ)
Title: Novel method of treatment
Inventor: CONLEY CREIGHTON
IPC: A61K47/38
Filed: 2000-04-11
Abstract: A modified release pharmaceutical formulation comprising amoxycillin and potassium clavulanate in a ration from 12:1 to 20:1 in which all of the potassium clavulanate and a first part of amoxycillin are formulated with pharmaceutically acceptable excipients which allow for immediate release of the potassium clavulanate and the first part of amoxycillin, to form an immediate release phase, and further comprising a second part of amoxycillin formulated with pharmaceutically acceptable excipients which allow for slow release of the second part amoxycillin, to form a slow release phase; said formulation may be in the form of a layered tablet.
Patent NZ-518208-A (NZ)
Title: Method for producing a tablet made of isomaltulose, isomalt or isomalt variants
Inventor: BAYERKOHLER THEODOR
IPC: A23L27/30
Filed: 2000-09-09
Abstract: Described is a method for producing a tablet and the tablet itself whereby the constituents are agglomerated. The tablet comprises isomaltulose, an equivocal mixture of 6-O-á-D-glycopyranosyl-D-sorbitol (1,6-GPS) and 6-O-á-D- glycopyranosyl -D-mannitol (1,6-GPM) or mixtures thereof in quantity ratios of 1,6-GPM to 1,6-GPS which differ from those of the equimolar mixture and/or contains other sugar alcohols.
Patent NZ-521389-A (NZ)
Title: 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds
Inventor: ENNIS MICHAEL DALTON
IPC: A61P25/00
Filed: 2001-03-08
Abstract: Diazepinoindole compounds, including those of formula I, are disclosed. These compounds are 5-HT ligands and are useful for treating diseases wherein modulation of 5-HT activity is desired, in particular, they are useful for treating a disease or disorder of the central nervous system.
Patent NZ-521777-A (NZ)
Title: Cellulose fiber treated with didecyldimethylammonium chloride (DDAC), didecyldimethylammonium bromide (DDAB) and/or water soluble copper salts having improved biostability
Inventor: REIMER JULIE A
IPC: D21C9/00
Filed: 2001-04-23
Abstract: A fibrous cellulose product resistant to biological degradation comprises cellulose fibers treated with a biocidally effective amount of a compound selected from the group consisting of didecyldimethylammonium chloride, didecyldimethylammonium bromide, water soluble copper salts, and mixtures thereof. Also described is a method for producing a cellulose fiber resistant to biological degradation comprising providing a cellulose fiber that has been at least partially purified by a chemical pulping process then treating the fiber with biocidally effective amount of a biocidal composition selected from the group consisting of didecyldimethylammonium chloride, didecyldimethylammonium bromide, water soluble copper salts, and mixtures thereof and then drying the fiber.
Patent NZ-522245-A (NZ)
Title: Dehydrated frozen confections such as ice cream made by freeze drying and containing sugar alcohol
Inventor: FUKINBARA ITARU
IPC: A23G9/44
Filed: 2002-10-25
Abstract: A dehydrated frozen confection obtained by freezing and then freeze-drying a starting material containing a milk content and a sweetener content, wherein at least 20%wt of the sweetener content is sugar-alcohol.
Patent NZ-524835-A (NZ)
Title: Timber drying kiln using different drying conditions in different chambers
Inventor: STUDD WILLIAM PAUL
IPC: F26B21/06
Filed: 2001-09-25
Abstract: A multichamber timber drying kiln in which different conditions are maintained in each chamber and methods of drying timber using such a kiln are disclosed. In one aspect timber is rapidly heated within a first chamber (2) and then transferred to a further chamber (3) for further drying. Timber may be transferred from the first chamber when the moisture content of the timber approaches the fiber saturation point. A preheating chamber (1) may be provided to preheat the timber before passing to the first chamber. A conditioning chamber (4) may be provided after the further chamber to condition the timber. Energy transfer means may be provided to transfer energy between chambers.
Patent NZ-526893-A (NZ)
Title: Isoindole-imide compounds, compositions, and uses thereof
Inventor: ROBARGE MICHAEL J
IPC: C07D401/02
Filed: 2001-12-21
Abstract: Isoindole-imide compounds of formula (I) and pharmaceutical compositions comprising these compounds are disclosed. The described compounds are useful for modulating the production of TNF-alpha, IL-1beta, IL-10, or T-cells in a mammal. The compounds are also useful in the manufacture of a medicament for treating cancer, an inflammatory disorder, or heart disease.
Patent NZ-534578-A (NZ)
Title: Apparatus for covering lumber stacks
Inventor: RYE MARCEL
Filed: 2004-08-05
Abstract: A covering apparatus, for covering a stack of horizontally aligned logs, comprises a tarpaulin engageable to a drag unit. The drag unit includes a laminar body 7, engagement means 2 for engaging the tarpaulin and securing means for securing a tow-line.
Patent NZ-536818-A (NZ)
Title: Tree stem or log appraising apparatus
Inventor: SEARLES GREGORY JOHN
Filed: 2004-11-24
Abstract: Apparatus for determining the velocity, V, or some function of V, of an impact induced vibration in a stem, log, or board is disclosed. A conveyor advances logs longitudinally to sequentially present an end of each log to an impact zone. An impact arm carrying an impact head is able to be cyclically swung into, and retrieved from, the impact zone. The impact head strikes the end of the log and a sensor detects the spectrum of the longitudinal vibration caused by the impact, and a processor can use this spectrum to determine the velocity of the vibrational response.
Patent NZ-540765-A (NZ)
Title: Product dispenser
Inventor: GAUTHIER JONATHAN C
IPC: H01M2/10
Filed: 2003-12-18
Abstract: A product dispenser is provided that enables product to be released from an adhesive attachment and transition from the interior of the dispenser to the exterior of the dispenser using a single rotation motion. The dispenser comprises a product platform, product adhesively secured to a strip and a base. The product platform comprises an upper surface and a lower surface and an opening through the platform. The adhesive strip comprises two major surfaces, one of which is free of adhesive and one with adhesive located on at least a portion thereof. The base comprises an upper surface and a lower surface and an opening through the base. The adhesive strip is threaded through both the product platform opening and the base opening and one end of the strip is attached to the lower surface of the base. The product platform and the base are fitted together so as to be rotatable with respect to each other about a common axis, with the lower surface of the product platform facing the upper surface of the base. The adhesive strip is positioned so that the non-adhesive surface of the strip is in contact with the upper surface of the product platform. Product, such as zinc air cells, are adhesively attached to the adhesive surface of the strip. In the case of zinc air cells, the adhesive strip functions as a tab until the cells are ready to be de-tabbed for activation and use. Rotation of either the base or the product platform so as to create relative motion between the two structures will cause the product to advance toward the opening in the product platform as the adhesive strip moves through the opening in the product platform. Product is separated from the adhesive strip as the strip moves through the product platform opening. Continued rotation advances the released product from the interior of the dispenser to the exterior of the dispenser.
Patent NZ-545325-A (NZ)
Title: Dynamic snubbing for LED lighting converter
Inventor: SCIANNA CARLO
IPC: H05B44/00
Filed: 2005-05-19
Abstract: A dynamic dummy load to allow a phase control dimmer to be used with LED lighting is disclosed. A dynamic dummy load provides a load to the dimmer when the LED electronics do not provide sufficient load due to start up issues or ringing in the circuit, the dynamic dummy load providing a reduced flow of current when the LED and its converter electronics provide sufficient current draw from the dimmer. The system generally includes a power source electrically connected to a phase control dimmer, the phase control dimmer electrically connected to converter circuitry to convert the AC power output of the dimmer to DC power output for powering the LED lighting, a dynamic dummy load electrically connected in parallel with the converter circuitry, the dummy load varying its current draw in response to operation of the converter circuitry.
Patent NZ-549205-A (NZ)
Title: Method and device for winding knitted nets
Inventor: WILLNER HORST
IPC: D04B27/34
Filed: 2005-02-16
Abstract: A method and a device for winding nets (1) knitted out of fringes (2) and weft threads (3) over a winding width pre-determined in a winding region. According to the method, the fringes (2) of the knitted net are guided along spacers (5, 9, 14) in front of the winding region.
Patent NZ-549846-A (NZ)
Title: System and method for selecting a view mode and setting
Inventor: BEAM TYLER K
IPC: G06F3/00
Filed: 2004-07-30
Abstract: A method for selecting a file view mode for a file list window in an operating system is provided. The method defines a presentation scheme for items presented in the file list window in an operating system. The method also allows a setting within that file view mode for one or more items in a screen display to be set. The method provided includes the steps of: obtaining a single user input via a slider input control indicative of a selection of one of a the available file view modes and also indicative of a selection of a setting within the selected file view mode, mapping the single user input to the selected file view mode, and mapping the single user input to the selected setting within that file view mode, where the selected file view mode and the selected setting define a presentation scheme for each of the items presented in the file list window on the screen display. A graphical user interface for the method, as well as computer based apparatus are also described.
Patent NZ-550528-A (NZ)
Title: Method and apparatus for thermally upgrading carbonaceous materials
Inventor: HOGSET ROBERT F
IPC: B01J8/00
Filed: 2005-03-11
Abstract: Carbonaceous materials are thermally upgraded in a pressurized steam environment to remove moisture and other by-products. A variety of water/solid separation devices may be employed in a process vessel to maximize moisture removal from the upgraded charge. Heating media inlet nozzles and process chamber vents are strategically positioned at the process vessel wall to minimize short circuiting of heating media to vessel outlet vents and to continuously separate hot water removed from the charge and condensed steam, such that the upgraded material removed from the process vessel is not discharged with accompanying free moisture. After upgrading, the charge may be rehydrated to improve its stability during shipping and storage.
Patent NZ-553554-A (NZ)
Title: Streptococcus antigens
Inventor: HAMEL JOSEE
IPC: A61P31/04
Filed: 2001-06-19
Abstract: Disclosed are Streptococcus polypeptides and polynucleotides encoding them. Said polypeptides may be useful vaccine components for the prophylaxis or therapy of streptococcus infection. Also disclosed are recombinant methods of producing the protein antigens.
Patent NZ-566015-A (NZ)
Title: 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission
Inventor: SONESSON CLAS
IPC: A61K31/445
Filed: 2006-10-12
Abstract: Disclosed is a 4-[3-fluoro-5-(methylsulfoynl)phenyl]piperidine derivative of formula (1), or a pharmaceutically selected salt thereof, wherein R is selected from C1-3alkyl and allyl. Also disclosed is the use of the compound to treat disorders of the central nervous system, such as Parkinson's disease, Parkinsonism, dyskinesias (including LDOPA induced dyskinesias), dystonias, tics, tremor, Huntington disease, iatrogenic and non-iatrogenic psychoses and hallucinoses, schizophrenia and schizophreniform disorders, bipolar disorder, mood and anxiety disorders, depression, obsessive-compulsive disease, neurodevelopmental disorders selected from Autism spectrum disorders, ADHD, Cerebral Palsy, Gilles de la Tourette's syndrome, dementia, age-related cognitive impairment, sleep disorders, sexual disorders, eating disorders, obesitas, headaches and other pains in conditions characterized by increased muscular tone, improvement of motor functions, cognitive functions and related emotional disturbances, and after brain injury induced by traumatic, inflammatory, infectious, neoplastic, vascular, hypoxic or metabolic causes or brain injury induced by toxic reactions to exogenous chemicals such as substances of abuse, pharmaceutical compounds, environmental toxins, a disorder related to substance abuse, Alzheimer's disease or related dementia disorders.
Patent NZ-571898-A (NZ)
Title: Reaction of 2-chloro-8-benzyloxyquinoline with 2-nitrophenylamine in the presence of 1,2-bis(diphenylphosphino)ethane (dppe), palladium catalyst and a base
Inventor: TOM NORMA JACQUELINE
IPC: C07D401/14
Filed: 2004-06-14
Abstract: Disclosed is a process for preparing (8-benzyloxy-quinolin-2-yl)-[4-(3-methyl-oxetan-3-ylmethoxy)-2-nitro-phenyl]-amine, the process comprising reacting about 1.2 equivalents of 4-(3-methyl-oxetan-3-ylmethoxy)-2-nitro-phenylamine with about 1 equivalent of 8-benzyloxy-2-chloroquinoline in the presence of about 0.06 equivalents of 1,2-bis(diphenylphosphino)ethane, about 0.02 equivalents of palladium acetate; about 1.4 equivalents of cesium carbonate, and toluene. (62) Divided Out of 543714
Patent NZ-576939-A (NZ)
Title: A Mortice Lock
Inventor: SWALES MICHAEL DAVID
IPC: E05B63/08
Filed: 2009-05-13
Abstract: A mortice lock is disclosed which has a lock casing which provides a first point of entrapment and a second point of entrapment, a latch bolt which can move between a latching position and an un-latching position, a handle for moving the latch bolt between the latching position and the un-latching position, a key cylinder, an operating assembly and a locking member. The operating assembly can move between a first position in which a deflectable portion of the operating assembly engages with the first point of entrapment and a second position in which the deflectable portion engages with the second point of entrapment. Only the key cylinder can move the operating assembly between the first position and the second position. The locking member (which is not a shoot bolt or part thereof) can move between a locking position in which a portion of the locking member engages with the latch bolt to prevent the latch bolt from moving into the un-latching position, and an unlocking position in which the latch bolt can move into the un-latching position. The locking member is operatively associated with the operating assembly such that moving the operating assembly into the first position moves the locking member into the unlocking position and moving the operating assembly into the second position moves the locking member into the locking position.
Patent NZ-577150-A (NZ)
Title: Imidazopyridine inhibitors of iap
Inventor: KOEHLER MICHAEL F
IPC: A61K31/437
Filed: 2007-12-14
Abstract: Disclosed are 2-(imidazo[1,2-a]pyridin-2-yl)pyrrolidine derivatives as represented by the general formula (I), wherein: X1 and X2 are each independently O or S; Y is CH2; Z is H, alkyl, a carbocycle or a heterocycle which may be substituted; Q is H, halogen, hydroxyl, carboxyl, amino, nitro, cyano, alkyl, a carbocycle or a heterocycle; wherein said alkyl, carbocycle and heterocycle may be substituted; R1, R3', R4', R5, R6 and R6' are each hydrogen; R2 is morpholino or cyclohexyl; R3 and R4 are methyl; R7 is H, cyano, hydroxyl, mercapto, halogen, nitro, carboxyl, amidino, guanidino, alkyl, a carbocycle, a heterocycle or -U-V; R8 is H, alkyl, a carbocycle or a heterocycle wherein one or more CH2 or CH groups of said alkyl is optionally replaced with -O-, -S-, -S(O)-, S(O)2, or -C(O)-; and said alkyl, carbocycle and heterocycle is optionally substituted; and m is 0 to 4; or a salt or stereoisomer thereof. Representative compounds include those where the 2-(imidazo[1,2-a]pyridin-2-yl)pyrrolidine moiety is substituted on the 1-position with N-methyl-L-alanine-L-cyclohexylglycine or N-methyl-L-alanine-L-morpholin-4-ylglycine. Further disclosed is a pharmaceutical composition which comprises a compound as defined above and a carrier, diluent or excipient for the treatment of cancer.
Patent NZ-580847-A (NZ)
Title: Paper wrapped foam cup and method of assembly
Inventor: PAYNE ROGER E
IPC: B65D1/00
Filed: 2005-04-07
Abstract: An apparatus 200 for automatically assembling a wrapper 104 to a foam cup 102 to form a wrapped foam cup 100 the apparatus 200 comprising a rotating platen 210 having multiple carriers, with each carrier sized to support a wrapper 104, and rotatable about a first axis of rotation, a heater for heating the wrapper 104 to a bonding temperature, a rotating mandrel assembly 212 comprising multiple rotatable mandrels, with each mandrel supporting a different cup 102 and freely rotatable about a second axis of rotation, wherein the rotating platen 210 and rotating mandrel assembly 212 are arranged relative to each other such that rotating the platen 210 about the first axis of rotation brings the platen 210 into contact with the foam cup 102 to effect the free rotation of the mandrel about the second axis of rotation to roll the foam cup 100 over the surface of the platen 210 to wrap the wrapper 104 on the platen 210 about the exterior of the foam cup 102. (62) Divided Out of 549555
Patent NZ-582056-A (NZ)
Title: Bicyclic heteroaryl compounds for treating conditions related to p2x7 receptor activation
Inventor: BAKTHAVATCHALAM RAJAGOPAL
IPC: C07D487/04
Filed: 2008-08-11
Abstract: Disclosed are compounds of formula Ia, salts and hydrates thereof, and methods for their preparation, where: U and Z1-Z4 are C or N RA comprises a substituted heteroaryl attached to the core structure through a linker moiety Specific examples of compounds of formula Ia include: N-(adamantan-1-ylmethyl)-1-pyrimidin-2-yl-1H-indole-3-carboxamide, N-{ [1-(4-methoxyphenyl)cyclohexyl]methyl} -1-pyrimidin-2-yl-4-(trifluoromethyl)-1H-indole-3-carboxamide, N-[2-(4-chlorophenyl)-2-piperidin-lylethyl]-4-fluoro-1-pyrimidin-2-yl-1H-indole-3-carboxamide, and N-[2-(4-chlorophenyl)-2-piperidin-1-ylethyl]-1-(3-cyanopyridin-2-yl)-4-methyl-1H-indole-3-carboxamide. Compounds of formula Ia are useful for treating a condition responsive to pain, inflammation, a neurological or neurodegenerative disorder, a cardiovascular disorder, an ocular disorder or an immune system disorder, steoarthritis, rheumatoid arthritis, arthrosclerosis, glaucoma, irritable bowel syndrome, inflammatory bowel disease, cirrhosis, lupus, scleroderma, Alzheimer's disease, traumatic brain injury, asthma, chronic obstructive pulmonary disease, or interstitial fibrosis..
Patent NZ-583586-A (NZ)
Title: Processes of producing alcohols by microbial fermentation of carbon monoxide
Inventor: SIMPSON SEAN DENNIS
IPC: C12P7/06
Filed: 2008-08-15
Abstract: Disclosed is a method for increasing the efficiency of capturing carbon and producing alcohol by microbial fermentation, the method comprising: a.) Culturing in a bioreactor, an isolate of the bacterium Clostridium autoethanogenum in a liquid nutrient medium; b.) Anaerobically fermenting a substrate comprising CO in the bioreactor of step (a) to produce one or more alchohols; c.) Monitoring a pH of the liquid nutrient medium to detect changes in the pH of the liquid nutrient medium; d.) If a change in the pH is detected, altering the pH of the liquid nutrient medium such that the pH is maintained within an optimum range for alcohol production, wherein the optimum range for alcohol production comprises substantially pH 4.5 to 6.5.